GSK, AstraZeneca in Talks to Help U.K. Government on Virus Tests
(Bloomberg) --
U.K. pharmaceutical giants GlaxoSmithKline Plc and AstraZeneca Plc are in talks to set up a lab to explore new ways of testing for the coronavirus to help overcome shortages of diagnostic materials, according to a person with knowledge of the plans.
The drugmakers will evaluate the use of different raw materials needed to carry out the tests and use their know-how and resources to help other companies or the U.K.'s National Health Service increase production, according to the person, who asked not to be identified because the details of the discussions aren't yet public.
U.K. Health Secretary Matt Hancock pledged Thursday to increase coronavirus testing to 100,000 a day by the end of April. The decision, announced at the government's daily press briefing, came after mounting criticism about the limited number of tests being done. Shortages of chemicals known as reagents and swabs used in tests have been blamed for delays.
As part of a new five-pillar approach to testing, Hancock said the government would work with pharmaceutical companies to help with the rapid increase.
“Our pharmaceutical giants like AstraZeneca and GSK, which have no great history in diagnostics, are now working with our world-leading, but small, diagnostics companies to build a British diagnostics industry at scale,” Hancock said.
A spokesman for AstraZeneca said in a statement Friday that the company had spoken with the government about helping and using its “in-house scientific capabilities to increase the effectiveness of the national testing effort,” but declined to comment on the specifics.
GSK has responded to requests to support U.K. efforts to expand testing for Covid-19, including providing lab equipment and scientific advice, the company said in a statement. While testing isn't a core activity, it is in discussions about other ways to help in the national effort, it said.
©2020 Bloomberg L.P.
-
Extracting Value From Battery Scrap Could Be Challenging For India | The Reason Why
A discarded lithium-ion battery still contains valuable materials such as lithium, nickel and cobalt. These can be recovered and reused. When such batteries are crushed and shredded, they produce a dark powder called black mass.
-
One El Nino, India Can Handle. Two Could Break The Granary
India's grain stocks can absorb one bad year, but a second El Nino could drain the buffer in two to three years, economists say.
-
India's Troika Of Good Luck | Joining The Dots
As Jensen Huang's exit drags Nvidia down, a cooling AI trade and resilient earnings have revived investor interest in India. A likely RBI rate hike looms.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.